Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fortress Biotech Inc (NASDAQ:FBIO)

2.51
Delayed Data
As of Feb 05
 -0.06 / -2.33%
Today’s Change
2.00
Today|||52-Week Range
5.35
-10.04%
Year-to-Date
No recent news for Fortress Biotech Inc.

Today’s Trading

Previous close2.57
Today’s open2.57
Day’s range2.47 - 2.67
Volume180,304
Average volume (3 months)109,713
Market cap$118.3M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+54.10%
Earnings growth (this year)-3.57%
Earnings growth (next 5 years)+26.22%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.09-4.33%
PETXAratana Therapeutics...-0.30-8.36%
DRNADicerna Pharmaceutic...-0.40-6.33%
GALEGalena Biopharma Inc-0.03-4.58%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lindsay Allan Rosenwald
CFO, Executive VP &
Head-Investor Relations
Lucy Lu
Corporate headquarters
New York, New York

Forecasts

Partner Offers